ARCHIVES

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

This article is from The Cancer Letter archive.

Vol. 28 No. 41 | November 8, 2002

Download PDF Visit The Full Archive

Related Articles

Studies Test New Agents Offering Relief From Treatment-Related Side Effects

July 30, 2004

NIH Seeks Candidates For Research Grants Division Director

September 8, 1995

National Cancer Institute Lists Approved Clinical Trials

January 31, 2003

ACS-Led National Cancer Dialogue Beset By Patient Mistrust, Lack Of Openness

January 21, 2000

Hatch Committee Clears Bill Blocking OMB Micromanagement

August 15, 1986

Moses To Lead AACI.

October 19, 2001